The tech company just isn't a serious competitor, yet.
News & Analysis: Teladoc Health
Even after the coronavirus is in our rearview mirror, Teladoc will still be with us.
Wall Street is nervous, but these companies see growth beyond the pandemic.
Like the popular cryptocurrency, these stocks are beaten down. But they have compelling growth prospects.
Things are different for the business in 2021 as lock-downs disappear and people venture out.
The virtual healthcare leader's first-quarter revenue growth was strong, but its earnings disappointed some investors.
Multiple purchases in Wood's ETFs appear to be a strong endorsement of the company.
Johnson & Johnson's time as the largest healthcare stock may be coming to an end.
Another bear market could be looming, but PayPal and Teladoc should prosper even if Wall Street takes a tumble.
The conditions are ripe for growth stocks to thrive.